Home › Juvenile Myelomonocytic Leukemia
Pag-aaral pangklinika para sa Juvenile Myelomonocytic Leukemia na nagre-recruit sa U.S.
9 pag-aaral para sa Juvenile Myelomonocytic Leukemia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Philadelphia, PA4 pag-aaral
- Minneapolis, MN4 pag-aaral
- Boston, MA3 pag-aaral
- Seattle, WA3 pag-aaral
- Memphis, TN3 pag-aaral
- Cincinnati, OH3 pag-aaral
- Atlanta, GA3 pag-aaral
- Chicago, IL3 pag-aaral
- Washington, DC3 pag-aaral
- Ann Arbor, MI3 pag-aaral
- San Francisco, CA3 pag-aaral
- New York City, NY3 pag-aaral
- Indianapolis, IN3 pag-aaral
Ayos sa estado
- California3 pag-aaral
- Colorado3 pag-aaral
- District of Columbia3 pag-aaral
- Florida3 pag-aaral
- Georgia3 pag-aaral
- Illinois3 pag-aaral
- Indiana3 pag-aaral
- Massachusetts3 pag-aaral
- Michigan3 pag-aaral
- Minnesota4 pag-aaral
- Missouri3 pag-aaral
- New York3 pag-aaral
- Ohio3 pag-aaral
- Pennsylvania4 pag-aaral
- Tennessee3 pag-aaral
- Texas3 pag-aaral
- Washington3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Nagre-recruitPhase 1/2
1 Month – 21 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Nagre-recruitPhase 1
Edad 1 hanggang 18 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Nagre-recruit
Hanggang edad 25 · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT03810196Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Nagre-recruitPhase 2
Hanggang edad 60 · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT03314974A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
Nagre-recruitPhase 1
Edad 12 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT04024761Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
Nagre-recruitPhase 2
6 Months – 39 Years · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT05800210HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Nagre-recruitPhase 1
Hanggang edad 80 · Lahat ng kasarian · Na-update May 18, 2026 · NCT03326921MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Nagre-recruitPhase 2
Hanggang edad 60 · Lahat ng kasarian · Na-update Abr 6, 2026 · NCT05735717Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.